ESHG Annual Meeting 2024 –
European Society of Human Genetics

Dr. Adam Kennedy, Ph.D., serves as the Director of Research and Development in Clinical Metabolomics at Metabolon, Inc. With a background in biochemistry and immunology, he boasts nearly 60 peer-reviewed publications and holds 5 patents, both awarded and pending. Dr. Kennedy’s career spans impactful roles including research at the National Institutes of Health (NIH), where he contributed to understanding the dissemination of S. aureus strains globally, and at the University of Virginia focusing on antibody therapies for leukemia/lymphoma.

Since joining Metabolon in 2010, Dr. Kennedy has directed over 200 projects and spearheaded the development of Metabolon’s inborn errors of metabolism screen utilizing global untargeted biochemical profiling. Leading a team of scientists, he has pioneered a rare disease screening test resulting in over 20 peer-reviewed publications and the identification of over 100 disease signatures. Dr. Kennedy’s contributions extend to initiatives for CLIA/CAP-validated tests targeting insulin resistance and impaired glucose tolerance. Through collaborative research in metabolic engineering, inflammation, and bioprocessing/cell culture analyses, Dr. Kennedy continues to advance interdisciplinary projects, showcasing his expertise in bridging research and development in clinical metabolomics.

Dr. Greg Michelotti is the Director of International Population Health at Metabolon, Inc., the global leader in metabolomics that offers the world’s largest metabolomics knowledge base. Dr. Michelotti earned his doctoral degree in biochemistry from the University of South Carolina and applied this training to elucidate the molecular mechanisms underpinning multi-organ stress response pathways. Since joining Metabolon, Dr. Michelotti leads biology efforts to identify metabolic signatures of disease in large human population cohorts to accelerate our understanding of the metabolic basis of human health and the transition to pathologic states. Before joining Metabolon, Dr. Michelotti led a translational research laboratory at Duke University incorporating a multi-omics approach to understand the molecular basis of liver disease and NASH progression. Collectively, his work has generated over 90 primary, peer-reviewed research publications, resulting in an h-index of 39. 

With extensive experience in clinical partnerships, Tim focuses his time developing key strategic multiomic collaborations. Prior to his time at Metabolon, Tim oversaw largescale population genomic projects (Genuity Science), consulted for pharma (Merck KGaA via S3 Group) and contributed to scaling up health tech start-ups (HealthFounders, TickerFit, Cortechs). Tim earned his MSc in Biotechnology & Business at UCD Michael Smurfit. 

Brenan is a Product Manager at Metabolon, specializing in strategic oversight and end-to-end management of the company’s product portfolio. He steers product strategy and development while also identifying competitive differentiators and assessing market opportunities. Brenan leverages a decade of metabolomics research experience with business expertise such as financial forecasts, including discounted cash flow analyses, to make informed strategic decisions to drive product success.

With a robust background in academia, Patrick brings a wealth of experience to his role at Metabolon. His tenure in academia was marked by numerous publications and successful grant acquisitions, attesting to his expertise and dedication. Patrick’s forte lies in optimizing project costs without compromising quality, making him an invaluable asset in translating research endeavors into pioneering discoveries. His commitment to driving innovation makes him the ideal partner to elevate your projects to new heights with Metabolon. 

Zoltan has over 25 years of experience providing researchers with services and products in various research fields in life sciences. He possesses strong skills in providing research-related services and offers both our preclinical and clinical analysis solutions to academic and industrial clients. Based in Berlin, he serves as your contact person in the DACH region.